Scarica l'app Stockscreener
19.14
3.53%
-0.70
Dopo l'orario di chiusura:
19.12
-0.02
-0.10%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
Best Healthcare Stocks To Add to Your WatchlistApril 5th - MarketBeat
2026-04-05 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Hims & Hers Health, Inc. (HIMS) And Encourages Shareholders to Reach Out | NYSE:HIMS | Press Release - Stockhouse
Hims & Hers Health, Inc. (HIMS) stock price, news, quote and history - Yahoo Finance Singapore
Hims Data Breach Tests Trust As Valuation Gap Attracts Investors - finance.yahoo.com
Novo partnership fuels long-term optimism for Hims & Hers Health, Inc. (HIMS) - MSN
Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data Breach - GlobeNewswire Inc.
Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data Breach - PR Newswire
Hims & Hers Health Faces Investor Lawsuit Over Alleged Misconduct - National Today
Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc.HIMS - Business Wire
Hims & Hers hack: Telehealth company reports customer support system breach - The American Bazaar
Barclays raises PT on Hims & Hers Health (HIMS) stock - MSN
HIMS Stock Gains As FDA Reportedly Moves Toward Lifting Restrictions On Peptides - Stocktwits
Healthcare Stocks To Watch TodayApril 3rd - MarketBeat
Hims & Hers warns of data breach after Zendesk support ticket breach - BleepingComputer
Hims & Hers Health, Inc. (HIMS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Hims and Hers reveal cyberattack — customer support system hacked and personal info stolen, here's what we know - TechRadar
Hims & Hers' Valuations Back To EarthRobust Monetization Trends Deserve Reiterated Buy - seekingalpha.com
Hims & Hers Health stock price forecast: sideways consolidation likely as HIMS falls 3.53% - Traders Union
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock - finance.yahoo.com
HIMS stock gains as FDA reportedly moves toward lifting restrictions on peptides - MSN
AI for investors - MLQ.ai
Security Breach and Trade Policy Fears Weigh on Hims & Hers Stock - AD HOC NEWS
Should You Buy Hims Stock Today? - theglobeandmail.com
Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know - finance.yahoo.com
Hims & Hers flags suspicious activity linked to third‑party customer service vendor - TradingView
Hims & Hers Data Breach Exposes Customer Service Records - Claim Depot
Building Better Health: AI as the Operating System for Care - Hims & Hers Newsroom
Broad selling pressure keeps Hims & Hers stock restrained after telehealth expansion news - Traders Union
Hims & Hers Health, Inc. (HIMS) Outperforms Broader Market: What You Need to Know - MSN
US FDA clarifies policies on compounding of GLP-1 medicines - Reuters
Hims & Hers Health Inc (HIMS) Stock Price, Trades & News - GuruFocus
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire
Hims & Hers Health Stock Short Interest Falls to 45.18% - Quiver Quantitative
-3.88% for Hims & Hers Health stock as oscillators give mixed signals near session low - Traders Union
Hims & Hers Stock Is Down 63% Over the Past 6 Months. Here’s Why the Valuation Still Looks Compelling - TIKR.com
Novo Partnership Fuels Long-Term Optimism for Hims & Hers Health, Inc. (HIMS) - Insider Monkey
Hims & Hers expands personalized digital healthcare platform - MSN
Hims & Hers Broadens Tailored Online Health Services Platform - Bitget
Hims & Hers Expands Personalized Digital Healthcare Platform - The Globe and Mail
Hims & Hers Health Inc (HIMS) Stock Price Up 6.42% on Mar 31 - GuruFocus
HIMS Gains as FDA Revisits Rules on Compounding Pharmacies - GuruFocus
Did Hims & Hers' Novo Nordisk GLP-1 Partnership Just Shift Hims & Hers Health's (HIMS) Investment Narrative? - Sahm
Hims Novo Nordisk GLP-1 Launch Ties Growth Story To Valuation Gap - simplywall.st
Hims & Hers Health, Inc. (HIMS) registers a bigger fall than the market: Important facts to note - MSN
HIMS Sees Moderate Bearish Sentiment Among Option Traders - GuruFocus
Hims & Hers Health, Inc. (HIMS) Registers a Bigger Fall Than the Market: Important Facts to Note - finance.yahoo.com
Hims & Hers Health Options Spot-On: On March 30th, 88,151 Contracts Were Traded, With 1.15 Million Open Interest - Moomoo
Assessing Hims & Hers Health (HIMS) Valuation After A Sharp Pullback And Long Term Shareholder Gains - Sahm
HIMS stock in spotlight after Hims & Hers adds Novo’s GLP-1 treatments to its platform - MSN
Why (HIMS) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Hims & Hers Health, Inc. (HIMS) Experiences a Sharper Decline Compared to the Overall Market: Key Points to Consider - bitget.com
Hims & Hers Health stock price forecast: persistent bearish setup as HIMS extends decline toward $18 - Traders Union
SG Americas Securities LLC Boosts Stock Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health Options Spot-On: On March 27th, 145.81K Contracts Were Traded, With 1.12 Million Open Interest - Moomoo
Hims & Hers Stock Decline Amid Legal Battles and Strategic Repositioning - StocksToTrade
Enovis, Neogen, Humana, LifeStance Health Group, and Hims & Hers Health Stocks Trade Down, What You Need To Know - Yahoo Finance
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):